A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance Leopold, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Port Saint Lucie, Florida, United States
- Facility name not stated
Sarasota, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Louisville, Kentucky, United States
- Facility name not stated
Durham, North Carolina, United States
- Facility name not stated
Huntersville, North Carolina, United States
- Facility name not stated
Winston-Salem, North Carolina, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jan 2015
- Primary completion
- 28 Aug 2019
- Completion
- 16 Oct 2020
- Last update posted
- 13 Jan 2022
- Registered enrollment
- 176
- Registry id
- NCT02318277
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.